TABLE 2.
T/C-1131 polymorphism | |||
---|---|---|---|
Males, N (%) | Females, N (%) | MI patients, N (%) | |
T/T | 1017 (85.4) | 1147 (83.9) | 366 (84.1) |
T/C | 152 (12.8) | 203 (14.8) | 46 (10.8) |
C/C | 22 (1.8) | 18 (1.3) | 23 (5.3) |
Ser/Trp19 polymorphism | |||
---|---|---|---|
(%) | Males, N (%) | Females, N (%) | MI patients, N |
Ser/Ser | 1037 (87.1) | 1161 (84.9) | 369 (84.8) |
Ser/Trp | 152 (12.7) | 200 (14.6) | 56 (12.9) |
Trp/Trp | 2 (0.2) | 7 (0.5) | 10 (2.3) |
Genotype | Ser/Trp19 | Ser/Ser | Ser/Trp | Trp/Trp |
---|---|---|---|---|
T/C-1131 | N (%) Total | 2198 (85.9) | 352 (13.8) | 9 (0.3) |
T/T | 2164 (84.6) | 1855 (72.5) | 302 (11.8) | 7 (0.3) |
T/C | 355 (13.9) | 308 (12.0) | 45 (1.8) | 2 (0.1) |
C/C | 40 (1.5) | 35 (1.3) | 5 (0.2) | 0 |